IP Library Granted Patent US 7,166,124
Granted Patent B2
US 7,166,124 · App. 10/104,391 · Granted Jan 23, 2007

Method for manufacturing sutureless bioprosthetic stent

Assignee: Providence Health System - Oregon
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,166,124
App. No.
10/104,391
Granted
Jan 23, 2007
Kind
B2
Abstract

A bioprosthetic stent graft is disclosed, having a stent frame and a biomaterial sheath suturelessly bonded to the stent frame. Sutureless bonding avoids sutures and substantially reducing medical complications in implantation of the stent graft. A device and method for manufacturing the stent graft further is disclosed. A mandrel is employed for shaping the stent graft, and means for irradiating the biomaterial effects sutureless bonding.

Claims (64)

1. A method for manufacturing a sutureless bioprosthetic stent graft suitable for physiological implantation, comprising:

wrapping a sheet of biomaterial on a mandrel to form a biomaterial roll having a first end, a second end, a lumen-facing first surface, an outward-facing second surface and an at least partial overlap of the biomaterial, the biomaterial first and second surfaces consisting essentially of an optically-transmissive collagen-rich matrix suitable for cell repopulation;

positioning a stent frame over the second surface of the biomaterial roll and intermediate the first and second ends of the biomaterial roll;

everting the first end of the biomaterial roll over the stent frame to encase the stent frame within apposed second surfaces of the biomaterial;

suturelessly bonding the biomaterial; and

removing the biomaterial roll from the mandrel;

wherein suturelessly bonding the biomaterial consists of photo-chemically cross-linking the collagen-rich matrix of the apposed second surfaces of the biomaterial by applying a photo-active crosslinking agent to the second surface to provide a photo-activable light absorptive surface on the optically-transmissive collagen rich matrix and irradiating at least the first end of the biomaterial roll with visible or UV light.

2. The method of claims 1 , wherein wrapping comprises aligning a first edge of the biomaterial sheet along the mandrel and rolling said mandrel.

3. The method of claim 1 , wherein everting the first end of the biomaterial roll over the stent frame comprises everting the first end of the biomaterial roll over the stent frame to approximate said first end with the second end.

4. The method of claim 1 , wherein the crosslinking agent is methylene blue.

5. The method of claim 4 , wherein irradiating the biomaterial roll with energy comprises irradiating the biomaterial roll with visible light.

6. The method of claim 4 , wherein irradiating the biomaterial roll with energy comprises irradiating the biomaterial roll with ultraviolet light.

7. The method of claim 1 , further comprising rotating the covered stent during irradiating.

8. The method of claim 1 , further comprising dehydrating the biomaterial prior to suturelessly bonding; and rehydrating the biomaterial contemporaneous with suturelessly bonding.

9. The method of claim 1 , wherein irradiating the biomaterial roll comprises irradiating substantially the entire second surface of the biomaterial roll.

10. The method of claim 1 , wherein irradiating the biomaterial roll comprises irradiating substantially the entire lumen-facing first surface of the biomaterial roll.

11. The method of claim 1 , wherein the biomaterial sheet consists essentially of collagen.

12. The method of claim 1 , wherein the biomaterial consists essentially of small intestine submucosa.

13. The method of claim 1 , wherein the biomaterial has incorporated therein a drug.

14. A method for manufacturing a sutureless bioprosthetic stent graft suitable for physiological implantation, comprising:

wrapping a sheet of biomaterial on a mandrel to form a biomaterial roll having a first end, a second end, a lumen-facing first surface, an outward-facing second surface and an at least partial overlap of the biomaterial, the biomaterial first and second surfaces consisting essentially of an optically-transmissive collagen-rich matrix suitable for cell repopulation;

positioning a stent frame over the second surface of the biomaterial roll and intermediate the first and second ends of the biomaterial roll;

everting the first end of the biomaterial roll over the stent frame to encase the stent frame within apposed second surfaces of the biomaterial;

applying to the second surface an energy absorbing material to provide a photo-activable wavelength-selective surface on the collagen-rich matrix that is energy-absorptive within a predetermined range of visible light wavelength and consists of an energy absorbing dye;

suturelessly bonding the biomaterial by irradiating at least the first end of the biomaterial roll with energy visible light of a wavelength within the predetermined range; and

removing the biomaterial roll from the mandrel,

wherein suturelessly bonding the biomaterial consists of irradiating the biomaterial roll sufficiently with light of said wavelength generated by a laser to at least partially thermally fuse the collagen rich matrix of the apposed second surfaces of the biomaterial sheet together.

15. The method of claim 14 , wherein the energy-absorbing dye is indocyanine green.

16. The method of claim 15 , wherein irradiating the biomaterial roll with energy generated by a laser includes irradiating the biomaterial roll with energy generated by a laser generating light having a wavelength of about 800 nm.

17. The method of claim 14 , further comprising applying an energy absorbing material that is energy absorptive within a predetermined range of light wavelengths and consists of an energy absorbing dye,

wherein suturelessly bonding the biomaterial includes suturelessly bonding selected loci on the biomaterial roll,

wherein the biomaterial consists essentially of small intestine submucosa,

and wherein suturelessly bonding selected loci on the biomaterial roll comprises irradiating the biomaterial roll at selected loci with light generated by a laser, said light being sufficient to at least partially thermally fuse the biomaterial sheet at the selected loci.

18. The method of claim 17 wherein the energy-absorbing dye is indocyanine green.

19. The method of claim 18 wherein irradiating the biomaterial roll at selected loci with energy generated by a laser includes irradiating the biomaterial roll at selected loci with energy generated by a laser emitting light having a wavelength of about 800 nm.

20. The method of claim 14 further comprising:

dehydrating the biomaterial prior to suturelessly bonding;

wherein suturelessly bonding the biomaterial roll includes contemporaneous rehydration of the biomaterial.

21. The method of claim 14 , wherein the biomaterial has incorporated therein a drug.

22. A method for manufacturing a sutureless bioprosthetic stent graft suitable for physiological implantation, comprising:

forming a biomaterial sheet into a biomaterial roll on a mandrel, said biomaterial roll having a first end, a second end, an inward-facing first surface, an outward-facing second surface and an at least partial overlap of the biomaterial, the biomaterial consisting essentially of small intestine submucosa;

positioning a stent frame over the biomaterial roll and intermediate the first and second ends thereof;

everting the first end of the biomaterial roll over the stent frame;

encasing the stent frame within the biomaterial sheet;

at least partially suturelessly bonding apposed second surfaces of the biomaterial roll; and

removing the biomaterial roll from the mandrel,

wherein suturelessly bonding the biomaterial roll consists of photo-chemically cross-linking the apposed second surfaces of the biomaterial by applying a photo-active crosslinking agent to the second surface and irradiating at least the first end of the biomaterial roll with visible or UV light.

23. The method of claim 22 wherein the crosslinking agent is methylene blue.

24. The method of claim 23 wherein irradiating the biomaterial roll with energy comprises irradiating the biomaterial roll with visible light.

25. The method of claim 23 wherein irradiating the biomaterial roll with energy comprises irradiating the biomaterial roll with ultraviolet light.

26. The method of claim 22 , further comprising rotating the covered stent during irradiating.

27. A method for manufacturing a sutureless bioprosthetic stent graft suitable for physiological implantation, comprising:

forming a biomaterial sheet into a biomaterial roll on a mandrel, said biomaterial roll having a first end, a second end, an inward-facing first surface, an outward-facing second surface and an at least partial overlap of the biomaterial, the biomaterial consisting essentially of small intestine submucosa;

positioning a stent frame over the biomaterial roll and intermediate the first and second ends thereof;

evening the first end of the biomaterial roll over the stent frame;

encasing the stent frame within the biomaterial sheet;

applying to the second surface of the biomaterial an energy absorbing material that is energy-absorptive within a predetermined range of visible light wavelengths consisting of an energy absorbing dye;

at least partially suturelessly bonding apposed second surfaces of the biomaterial roll; and

removing the biomaterial roll from the mandrel,

wherein suturelessly bonding the biomaterial roll consists of irradiating the biomaterial roll sufficiently with visible light of said wavelength generated by a laser to at least partially thermally fuse the apposed second surfaces of the biomaterial sheet together.

28. The method of claim 27 wherein the energy-absorbing dye is indocyanine green.

29. The method of claim 28 wherein irradiating the biomaterial roll with energy sufficient to at least partially thermally fuse the biomaterial sheet with energy generated by a laser includes irradiating the biomaterial roll with energy sufficient to at least partially thermally fuse the biomaterial sheet with energy generated by a laser emitting light having a wavelength of about 800 nm.

30. The method of claim 27 wherein suturelessly bonding the biomaterial roll comprises suturelessly bonding selected loci on the apposed second surfaces of the biomaterial roll.

31. The method of claim 27 wherein suturelessly bonding the biomaterial roll comprises suturelessly bonding selected loci on the biomaterial roll by irradiating the biomaterial roll at selected loci with energy generated by a laser, said energy being sufficient to at least partially thermally fuse the biomaterial sheet.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 28, 2017
From: PROVIDENCE HEALTH AND SERVICES
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 043026/0901 →
CONFIRMATORY LICENSE Recorded Oct 25, 2004
From: PROVIDENCE HEALTH SYSTEM-OREGON
To: ARMY, UNITED STATES GOVERNMENT, THE, SECRETARY OF THE ARMY MEDICAL RESEARCH AND MATERIEL COMMAND
Reel/Frame 015912/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2002
From: XIE, HUA; BUCKLEY, LISA A.
To: PROVIDENCE HEALTH SYSTEM - OREGON
Reel/Frame 013278/0058 →
Continuity (1)
Related Publication 20030181968A1 · Sep 25, 2003